All Stories

  1. Author Correction: In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions
  2. In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions
  3. Mapping where and when necroptotic cell death occurs in disease
  4. MLKL deficiency protects against low-grade, sterile inflammation in aged mice
  5. The web of death: the expanding complexity of necroptotic signaling
  6. Development of a carotid artery thrombolysis stroke model in mice
  7. A common humanMLKLpolymorphism confers resistance to negative regulation by phosphorylation
  8. Endothelial Caspase-8 prevents fatal necroptotic hemorrhage caused by commensal bacteria
  9. Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
  10. Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling
  11. Tankyrase-mediated ADP-ribosylation is a regulator of TNF-induced death
  12. The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL
  13. Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL
  14. Ferroptosis mediates selective motor neuron death in amyotrophic lateral sclerosis
  15. Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL
  16. Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis
  17. A toolbox for imaging RIPK1, RIPK3, and MLKL in mouse and human cells
  18. Location, location, location: A compartmentalized view of TNF-induced necroptotic signaling
  19. Necroptosis is dispensable for the development of inflammation-associated or sporadic colon cancer in mice
  20. A toolbox for imaging RIPK1, RIPK3 and MLKL in mouse and human cells
  21. MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis
  22. Identification of MLKL membrane translocation as a checkpoint in necroptotic cell death using Monobodies
  23. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS
  24. VDAC2 enables BAX to mediate apoptosis and limit tumor development
  25. Endogenous fibrinolysis facilitates clot retraction in vivo
  26. Protein aggregation or liberation during cell necrosis
  27. Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains
  28. MouseMove: an open source program for semi-automated analysis of movement and cognitive testing in rodents
  29. Dendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by Plasmin
  30. Activated platelets rescue apoptotic cells via paracrine activation of EGFR and DNA-dependent protein kinase
  31. Oxidation of an Exposed Methionine Instigates the Aggregation of Glyceraldehyde-3-phosphate Dehydrogenase
  32. Tissue-type plasminogen activator is an extracellular mediator of Purkinje cell damage and altered gait
  33. Nucleocytoplasmic Coagulation: An Injury-Induced Aggregation Event that Disulfide Crosslinks Proteins and Facilitates Their Removal by Plasmin
  34. The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans
  35. Neovascularization Is Attenuated With Aldosterone Synthase Inhibition in Rats With Retinopathy
  36. Compartment- and context-specific changes in tissue-type plasminogen activator (tPA) activity following brain injury and pharmacological stimulation
  37. Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin
  38. Novel Role of Platelets in Mediating Inflammatory Responses and Ventricular Rupture or Remodeling Following Myocardial Infarction
  39. A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury
  40. Low molecular weight contaminants in commercial preparations of plasmin and t-PA activate neurons
  41. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function
  42. Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor
  43. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
  44. Tissue-Type Plasminogen Activator: A Multifaceted Modulator of Neurotransmission and Synaptic Plasticity
  45. Vampire Bat Salivary Plasminogen Activator (Desmoteplase): A Unique Fibrinolytic Enzyme That Does Not Promote Neurodegeneration